Consequently, the metabolic effects of timed daily bromocriptine treatment observed in this study may in part derive from a reduction of plasma hyperprolactinemia and normalization of the daily rhythm of plasma prolactin level towards that of lean, insulin sensitive rats. This evidence concerns the gene INS and hyperprolactinemia.